Oura Commits $625 Million in Cash to Counsel Health Acquisition
Oura has entered into a definitive agreement to acquire Counsel Health, an AI-native primary-care company, for $625 million in cash, subject to purchase-price adjustments, according to Counsel Health’s announcement published November 10, 2026. The companies expect the transaction to close…
Cepheid’s 13-Pathogen Respiratory Panel Gains IVDR CE Mark
Cepheid, a Danaher company, announced on November 10, 2026 that its Xpert Respiratory Panel had achieved CE marking under the in vitro medical device regulation (IVDR). The multiplex PCR test is designed to detect 13 common viral and bacterial respiratory…
RF Medical’s Mi-BLATOR Microwave Ablation System Receives CE Marking
RF Medical said in a November 10, 2026 announcement that its Mi-BLATOR microwave ablation system had obtained CE marking under the European Union’s Medical Device Regulation. The certification covers both the microwave generator and antennas, enabling the South Korean device…
ZEISS PT LUNANA Lens Wins China Approval With Launch Planned for 2027
Carl Zeiss Meditec announced on November 9, 2026 that China’s National Medical Products Administration (NMPA) had recently approved the ZEISS PT LUNANA phakic intraocular lens (pIOL), the first product in its Phakic Technology family, with commercialization planned first in China…
Simtra Opens $250 Million-Plus Building H With Vial Line Due in 2027
Simtra BioPharma Solutions announced the November 9, 2026, opening of Building H, a more than $250 million expansion of its Bloomington, Indiana, manufacturing campus. The 153,000-square-foot facility adds prefilled-syringe, vial and lyophilization capabilities for the contract development and manufacturing organization,…
Lunit Secures Saudi Health System Contract for Two Imaging AI Tools
Lunit announced on November 9, 2026 that it will supply artificial intelligence software for chest X-ray and mammography analysis to Saudi Arabia’s Ministry of National Guard Health Affairs (MNGHA), adding a government healthcare system to its Saudi customer base. The…
Photocure Keeps 2028 Medicare Plan After AssureMDx Exclusion
Photocure retained its 2028 Medicare coverage planning assumption for the AssureMDx bladder-cancer test in a November 9, 2026 announcement, after Novitas Solutions said the test would remain noncovered for risk stratification in patients with microhematuria. The Norwegian diagnostics company continues…
Mentari Closes InMed Merger After $490 Million in Private Financing
InMed Pharmaceuticals , now Mentari Therapeutics, announced in a November 6, 2026 closing release that it had completed its all-stock merger with privately held Mentari Therapeutics after pre-merger Mentari closed private financings totaling approximately $490 million in gross proceeds. The…
Zylox, GL Capital to Invest HK$1.48B in LifeTech Pending Conditions
LifeTech Scientific announced on November 6, 2026 that Zylox-Tonbridge Medical Technology and GL Capital had conditionally agreed to an approximately HK$1.48 billion subscription for new LifeTech shares. The proposed investment establishes an initial step toward a broader vascular and structural-heart…
Astrana Health Q3 Revenue Tops $1 Billion as Profit Surges
Astrana Health reported on November 5, 2026 that third-quarter revenue rose 7% to $1.02 billion from $956.0 million a year earlier, while income from operations increased to $39.9 million from $19.2 million for the quarter ended September 30, 2026. The…
Belfast’s PulseAI Gains 510(k) Clearance for Wearable ECG AI
PulseAI announced on November 5, 2026 that the U.S. Food and Drug Administration had granted 510(k) clearance for its AI-powered arrhythmia analysis model for wearables, giving the Belfast medical technology company a regulatory milestone as it seeks to integrate automated…
Neuros Medical’s ALTIUS Receives Medicare Pass-Through Status
Neuros Medical announced the reimbursement decision on November 5, 2026 that the Centers for Medicare & Medicaid Services has finalized Medicare transitional pass-through status for its ALTIUS Direct Electrical Nerve Stimulation System. Beginning January 1, 2027, the decision establishes separate…
BD Q4 GAAP EPS Rises 110% as Revenue Grows 5.4% to $5.27 Billion
Fourth-quarter revenue at BD rose 5.4% to $5.274 billion and GAAP diluted earnings per share from continuing operations climbed 110% to $2.52, the company said in its fiscal 2026 results released November 5, 2026, as lower operating costs lifted earnings…
BD Raises Dividend for 55th Year and Adds 10 Million Shares to Buyback
BD (Becton, Dickinson and Company ) announced on November 5, 2026 that its board raised the quarterly common-stock dividend 1.0% to $1.06 per share and authorized repurchases of up to 10 million additional shares, extending its annual dividend-increase streak to…
Accuray Revenue Falls 8% as Product Sales and Orders Decline
Accuray reported on November 4, 2026 that fiscal first-quarter revenue fell 8% year over year to $86.5 million for the three months ended September 30, 2026. Product revenue declined 26%, while gross product orders fell to $19.8 million from $39.6…
